Skip to content

Clinical trials

Phase 1/2 Carcinoma, Hepatocellular trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Hepatocellular Phase: Phase 1/2 Country / region: Spain Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20141
20162
20173
20182
20192
20201
20211
20222
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting5
Recruiting3
Terminated2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Eisai Inc.3
Celgene2
Eli Lilly and Company2
Amgen1
AstraZeneca1
BioInvent International AB1
Cellestia Biotech AG1
Daiichi Sankyo1
Forma Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular25
Colorectal Neoplasms6
Carcinoma, Non-Small-Cell Lung5
Melanoma5
Carcinoma, Transitional Cell4
Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Endometrial Neoplasms3
Glioblastoma3
Liver Neoplasms3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.